Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lipman

Showing results (321-330 of 342) with videos related to

Pageof 35
Sort By:
Plos Biology|July 20, 2005
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 virusesEdward C Holmes, Elodie Ghedin, Naomi Miller, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 8, 2023
US air pollution is associated with increased incidence of non-syndromic cleft lip/palateKelsi N Krakauer, Priscila C Cevallos, Uche O Amakiri, et al.
Cancer|April 13, 2018
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signaturesDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
American Journal of Surgery|September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgeryN J Meropol, N J Petrelli, B J Lipman, et al.
International Journal of Antimicrobial Agents|September 4, 2019
Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionS A M Dhaese, P Colin, H Willems, et al.
Intensive Care Medicine|March 31, 2015
Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Intensive Care Medicine|July 24, 2014
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Anaesthesia and Intensive Care|October 6, 2011
Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New ZealandR J Boots, J Lipman, M Lassig-Smith, et al.
International Journal of Antimicrobial Agents|March 18, 2014
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI StudyJ A Roberts, V Stove, J J De Waele, et al.
Human Genetics|January 10, 2013
Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibilityMateusz Siedlinski, Dustin Tingley, Peter J Lipman, et al.
Pageof 35

Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
Plos Biology|July 20, 2005
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 virusesEdward C Holmes, Elodie Ghedin, Naomi Miller, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 8, 2023
US air pollution is associated with increased incidence of non-syndromic cleft lip/palateKelsi N Krakauer, Priscila C Cevallos, Uche O Amakiri, et al.
Cancer|April 13, 2018
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signaturesDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
American Journal of Surgery|September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgeryN J Meropol, N J Petrelli, B J Lipman, et al.
International Journal of Antimicrobial Agents|September 4, 2019
Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionS A M Dhaese, P Colin, H Willems, et al.
Intensive Care Medicine|March 31, 2015
Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Intensive Care Medicine|July 24, 2014
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patientsJan J De Waele, J Lipman, M Akova, et al.
Anaesthesia and Intensive Care|October 6, 2011
Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New ZealandR J Boots, J Lipman, M Lassig-Smith, et al.
International Journal of Antimicrobial Agents|March 18, 2014
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI StudyJ A Roberts, V Stove, J J De Waele, et al.
Human Genetics|January 10, 2013
Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibilityMateusz Siedlinski, Dustin Tingley, Peter J Lipman, et al.
Pageof 35